FDA Inspection
Baxter Pharmaceuticals India Pvt LtdBaxter Pharmaceuticals India Pvt Ltd – FDA Inspection, Jun 27, 2025
Record Details
This FDA Inspection record concerns Baxter Pharmaceuticals India Pvt Ltd, with an inspection on June 27, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · c9ba557a-8f12-4507-9e6e-b0238c141295
Inspection Facts
- Inspection number
- 1280282
- FDA center
- Human Drugs
Other FDA inspections of Baxter Pharmaceuticals India Pvt Ltd
10| Date | Classification | Office | Project area |
|---|---|---|---|
| January 27, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 4, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2017 | Not classified | Office of Inspections and Investigations | |
| August 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Baxter Pharmaceuticals India Pvt Ltd
- FDA Inspection 1195842 - 2023-01-27
- FDA Inspection 1169631 - 2022-05-17
- FDA Inspection 1028732 - 2017-08-04
- FDA Inspection 1019107 - 2017-05-31
- FDA Inspection 986348 - 2016-08-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.